Pandion Therapeutics Inc (PAND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | |
| Sales | 8,779 | 967 | 0 |
| Gross Profit | 8,779 | 967 | N/A |
| Operating Expenses | 46,708 | 23,186 | 11,049 |
| Operating Income | -37,929 | -22,219 | -11,049 |
| Interest Expense | 334 | 26 | 13 |
| Other Income | 158 | 368 | 175 |
| Pre-tax Income | -38,105 | -21,877 | -10,887 |
| Net Income Continuous | -38,105 | -21,877 | -10,887 |
| Net Income | $-38,105 | $-21,877 | $-10,887 |
| EPS Basic Total Ops | -3.17 | -25.00 | -17.00 |
| EPS Basic Continuous Ops | -2.81 | -21.16 | -14.01 |
| EPS Diluted Total Ops | -3.17 | -25.00 | -17.00 |
| EPS Diluted Continuous Ops | -2.81 | -21.16 | -14.01 |
| EBITDA(a) | $-37,417 | $-21,977 | $-10,955 |